SYNAPSE RESEARCH MANAGEMENT PARTNERS SL
- Country
- Spain
- Type
- Beneficiary
- Website
- www.synapse-managers.com
- Grants received
- 33
Funding record
- 33 grants on record
- €22,101,733.97 awarded in total
- 2008–2025 years covered
This total adds up only the grants our sources publish. It is not the total funding this organisation has received.
Programmes
18 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations funded alongside this one on two or more projects. Sharing a single project does not count. Some projects have as many as 195 participants, and appearing on the same list once is not a working relationship.
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
- JANSSEN PHARMACEUTICA NV
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
- ALZHEIMER EUROPE
- NOVARTIS PHARMA AG
- NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
- SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
- KAROLINSKA INSTITUTET
Calls from this organisation
No published calls from this organisation.
Grants received
- Patient Relevant Osteoarthritis endpoints using Big data Evaluation
- Testing, improving, and co-creating Guidance and Tools for Real World Evidence Generation in Europe and use for Decision-Making in Europe: GREG
- Research in Europe and Diversity Inclusion
- Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research
- REAL-WORLD IMPLEMENTATION, DEPLOYMENT AND VALIDATION OF EARLY DETECTION TOOLS AND LIFESTYLE ENHANCEMENT
- Support Utilisation of Sustainable and TAilored INnovative methods for HTA
- CLinical impact through AI-assisted MS care
- PRECISION MEDICINE PLATFORM IN NEURODEGENERATIVE DISEASE
- European platform for neurodegenerative disorders
- EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS
- EU Patient- cEntric clinicAl tRial pLatform
- Efficiently Networking European Neurodegeneration Research
- Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe
- Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.
- Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.